UNSTRUCTURED
Telemedicine has revolutionized pediatric dermatology by offering remote access to specialized care and reducing healthcare costs. The integration of Artificial Intelligence (AI) further enhances diagnostic accuracy and efficiency, transforming patient outcomes. This review examines the current literature on telemedicine and AI in pediatric dermatology, highlighting studies on improved access to care, economic benefits, and diagnostic advancements. Telemedicine has significantly improved access for pediatric patients, particularly in underserved regions, with teledermatology consultations increasing access by up to 75% and reducing healthcare costs by up to 30%. Virtual consultations enhance convenience for families, with 80% of parents preferring teledermatology over traditional visits. AI-powered diagnostic tools achieve over 90% accuracy in identifying skin conditions, supporting early detection and effective treatment planning. Despite these benefits, ethical challenges such as data privacy, security, and algorithmic bias must be addressed to ensure equitable care. The integration of AI into telemedicine augments diagnostic capabilities, enabling accurate and timely interventions for conditions like atopic dermatitis and genetic skin disorders. Developing AI algorithms tailored to pediatric patients and inclusive of diverse skin types is crucial to minimize biases. Continuous multidisciplinary collaboration is essential for comprehensive care. In conclusion, telemedicine and AI are valuable tools in pediatric dermatology, enhancing access, reducing costs, and improving diagnostic accuracy. Addressing ethical challenges and ensuring equitable access are crucial for the continued success of these technologies. Future advancements are expected to integrate predictive analytics and personalized treatment plans, ultimately improving health outcomes and quality of life for pediatric patients.